Description
Fixaura-CV Tablets contain Cefixime Trihydrate 200 mg and Potassium Clavulanate 125 mg, a combination of antibacterial agents used for the treatment of susceptible bacterial infections. Cefixime is a third-generation cephalosporin antibiotic that works by interfering with bacterial cell wall synthesis, while Clavulanate helps inhibit certain beta-lactamase enzymes produced by bacteria, supporting the antibacterial activity of Cefixime. Fixaura-CV may be prescribed for selected infections affecting the respiratory tract, urinary tract, ear, nose and throat, and other areas, depending on the causative organism and clinical assessment. It should be taken only as prescribed by a doctor, with the recommended dosage and duration followed carefully. This medicine is not effective against viral infections such as the common cold or flu.
